These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing. Masetti R; Castelli I; Astolfi A; Bertuccio SN; Indio V; Togni M; Belotti T; Serravalle S; Tarantino G; Zecca M; Pigazzi M; Basso G; Pession A; Locatelli F Oncotarget; 2016 Aug; 7(35):56746-56757. PubMed ID: 27462774 [TBL] [Abstract][Full Text] [Related]
5. [Clonal evolution of myeloid malignancies]. Kon A Rinsho Ketsueki; 2020; 61(9):1120-1129. PubMed ID: 33162507 [TBL] [Abstract][Full Text] [Related]
6. Clonal evolution of acute myeloid leukemia from diagnosis to relapse. Vosberg S; Greif PA Genes Chromosomes Cancer; 2019 Dec; 58(12):839-849. PubMed ID: 31478278 [TBL] [Abstract][Full Text] [Related]
7. Clonal dynamics in a single AML case tracked for 9 years reveals the complexity of leukemia progression. Kim T; Yoshida K; Kim YK; Tyndel MS; Park HJ; Choi SH; Ahn JS; Jung SH; Yang DH; Lee JJ; Kim HJ; Kong G; Ogawa S; Zhang Z; Kim HJ; Kim DD Leukemia; 2016 Feb; 30(2):295-302. PubMed ID: 26424407 [TBL] [Abstract][Full Text] [Related]
8. Genetic heterogeneity and clonal evolution in acute myeloid leukemia. Romer-Seibert JS; Meyer SE Curr Opin Hematol; 2021 Jan; 28(1):64-70. PubMed ID: 33186150 [TBL] [Abstract][Full Text] [Related]
9. Clonal heterogeneity as detected by metaphase karyotyping is an indicator of poor prognosis in acute myeloid leukemia. Bochtler T; Stölzel F; Heilig CE; Kunz C; Mohr B; Jauch A; Janssen JW; Kramer M; Benner A; Bornhäuser M; Ho AD; Ehninger G; Schaich M; Krämer A J Clin Oncol; 2013 Nov; 31(31):3898-905. PubMed ID: 24062393 [TBL] [Abstract][Full Text] [Related]
10. [Acute myeloid leukemia: molecular pathogenesis and new therapeutic strategies]. Goyama S Rinsho Ketsueki; 2016 Feb; 57(2):118-28. PubMed ID: 26935629 [TBL] [Abstract][Full Text] [Related]
11. Functional heterogeneity of genetically defined subclones in acute myeloid leukemia. Klco JM; Spencer DH; Miller CA; Griffith M; Lamprecht TL; O'Laughlin M; Fronick C; Magrini V; Demeter RT; Fulton RS; Eades WC; Link DC; Graubert TA; Walter MJ; Mardis ER; Dipersio JF; Wilson RK; Ley TJ Cancer Cell; 2014 Mar; 25(3):379-92. PubMed ID: 24613412 [TBL] [Abstract][Full Text] [Related]
12. AML evolution from preleukemia to leukemia and relapse. Shlush LI; Mitchell A Best Pract Res Clin Haematol; 2015; 28(2-3):81-9. PubMed ID: 26590763 [TBL] [Abstract][Full Text] [Related]
16. Genetic diversity within leukemia-associated immunophenotype-defined subclones in AML. Tiso F; Koorenhof-Scheele TN; Huys E; Martens JHA; de Graaf AO; van der Reijden BA; Langemeijer SMC; Preijers FWMB; Kroeze LI; Jansen JH Ann Hematol; 2022 Mar; 101(3):571-579. PubMed ID: 35024892 [TBL] [Abstract][Full Text] [Related]
17. Clonal competition within complex evolutionary hierarchies shapes AML over time. Sandén C; Lilljebjörn H; Orsmark Pietras C; Henningsson R; Saba KH; Landberg N; Thorsson H; von Palffy S; Peña-Martinez P; Högberg C; Rissler M; Gisselsson D; Lazarevic V; Juliusson G; Ågerstam H; Fioretos T Nat Commun; 2020 Feb; 11(1):579. PubMed ID: 32024830 [TBL] [Abstract][Full Text] [Related]
18. A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia. Kirtonia A; Pandya G; Sethi G; Pandey AK; Das BC; Garg M J Mol Med (Berl); 2020 Aug; 98(8):1069-1091. PubMed ID: 32620999 [TBL] [Abstract][Full Text] [Related]
19. Prospective Isolation and Characterization of Genetically and Functionally Distinct AML Subclones. de Boer B; Prick J; Pruis MG; Keane P; Imperato MR; Jaques J; Brouwers-Vos AZ; Hogeling SM; Woolthuis CM; Nijk MT; Diepstra A; Wandinger S; Versele M; Attar RM; Cockerill PN; Huls G; Vellenga E; Mulder AB; Bonifer C; Schuringa JJ Cancer Cell; 2018 Oct; 34(4):674-689.e8. PubMed ID: 30245083 [TBL] [Abstract][Full Text] [Related]
20. High-throughput single-cell DNA sequencing of acute myeloid leukemia tumors with droplet microfluidics. Pellegrino M; Sciambi A; Treusch S; Durruthy-Durruthy R; Gokhale K; Jacob J; Chen TX; Geis JA; Oldham W; Matthews J; Kantarjian H; Futreal PA; Patel K; Jones KW; Takahashi K; Eastburn DJ Genome Res; 2018 Sep; 28(9):1345-1352. PubMed ID: 30087104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]